澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AMPLIA THERAPEUTICS LTD

0.240

-0.005-2.04%

成交量：908.17萬

成交額：217.17萬

市值：1.23億

市盈率：-11.90

高：0.252

開：0.230

低：0.227

收：0.245

52周最高：0.425

52周最低：0.049

股本：5.13億

流通股本：3.51億

量比：0.35

換手率：2.59%

股息：- -

股息率：- -

每股收益(TTM):-0.020

每股收益(LYR):-0.021

淨資產收益率：-28.49%

總資產收益率：-17.71%

市淨率：2.87

市盈率(LYR):-11.22

資料載入中...

總覽公司新聞資訊公告

Amplia Therapeutics胰腺癌試驗再獲四例完全緩解總體生存數據持續改善

Amplia與韓國專業藥物篩選公司Next&Bio簽署第二項協議，探索Fak抑制劑與Kras抑制劑的聯合治療

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ATX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","market":"AU","secType":"STK","nameCN":"AMPLIA THERAPEUTICS LTD","latestPrice":0.24,"timestamp":1774847520000,"preClose":0.245,"halted":0,"volume":9081723,"delay":0,"changeRate":-0.02040816326530614,"nameEN":"AMPLIA THERAPEUTICS LTD","floatShares":351321835,"shares":513071629,"eps":-0.020164,"marketStatus":"已收盤","change":-0.005,"latestTime":"03-30 16:12:00 AEDT","open":0.23,"high":0.252,"low":0.227,"amount":2171742,"amplitude":0.102041,"askPrice":0.24,"askSize":308313,"bidPrice":0.235,"bidSize":4242,"shortable":3,"etf":0,"ttmEps":-0.020164,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774911600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.245,"openAndCloseTimeList":[[1774825200000,1774846800000]],"volumeRatio":0.347947,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATX.AU","preClose":0.245,"auctionPrice":0.24,"auctionVolume":36700,"auctionTime":1774847401388,"referencePrice":0.24,"referenceTime":1774863003090,"auction":3,"marketStatus":"盘后竞价","timestamp":1774847401388}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","floatShares":351321835,"roa":"-17.71%","roe":"-28.49%","lyrEps":-0.021392,"volumeRatio":0.347947,"shares":513071629,"dividePrice":0,"high":0.252,"amplitude":0.102041,"preClose":0.245,"low":0.227,"week52Low":0.049,"pbRate":"2.87","psRate":"24.59","week52High":0.425,"institutionHeld":0,"latestPrice":0.24,"committee":-0.972856,"eps":-0.020164,"divideRate":0,"volume":9081723,"delay":0,"ttmEps":-0.020164,"open":0.23,"prevYearClose":0.15,"prevWeekClose":0.245,"prevMonthClose":0.12,"prevQuarterClose":0.15,"fiveDayClose":0.235,"twentyDayClose":0.12,"sixtyDayClose":0.17,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-18","symbol":"ATX.AU","defaultRemindTime":1713398400000,"type":"split","dateTimestamp":1713362400000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113965610","title":"Amplia Therapeutics胰腺癌試驗再獲四例完全緩解 總體生存數據持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1113965610","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113965610?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 20:45","pubTimestamp":1774269918,"startTime":"0","endTime":"0","summary":"生物制药企业AmplIA THERAPEUTICS LTD最新临床数据显示，其针对胰腺癌的ACCENT试验取得突破性进展。该研究在原有成果基础上新增四例完全缓解病例，同时患者总体生存期呈现显著延长趋势。此次数据更新进一步验证了候选药物在晚期胰腺癌治疗领域的潜力，为后续研发提供重要临床依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATX.AU"],"gpt_icon":0},{"id":"1115223185","title":"Amplia與韓國專業藥物篩選公司Next&Bio簽署第二項協議，探索Fak抑制劑與Kras抑制劑的聯合治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115223185","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115223185?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 21:45","pubTimestamp":1766151919,"startTime":"0","endTime":"0","summary":"Amplia与韩国专业药物筛选公司Next&Bio签署第二项协议，探索Fak抑制剂与Kras抑制剂的联合治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATX.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}